These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 32455140

  • 1. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
    Jin W, Fei X, Wang X, Chen F, Song Y.
    J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE, Abdul-Maksoud RS, Elsayed WSH, Desoky EAM.
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [Abstract] [Full Text] [Related]

  • 3. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI, Morales-Montor JG, Rangel-Escareño C, Langley E, Peralta-Zaragoza O, Cruz Colin JL, Rodriguez-Dorantes M.
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [Abstract] [Full Text] [Related]

  • 4. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y, Qin S, An T, Tang Y, Huang Y, Zheng L.
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [Abstract] [Full Text] [Related]

  • 5. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
    Pang C, Liu M, Fang W, Guo J, Zhang Z, Wu P, Zhang Y, Wang J.
    Cell Physiol Biochem; 2016 Jul; 39(3):1111-7. PubMed ID: 27562849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
    Kachakova D, Mitkova A, Popov E, Popov I, Vlahova A, Dikov T, Christova S, Mitev V, Slavov C, Kaneva R.
    DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y, Eroğlu O.
    Microrna; 2020 Mar; 9(4):303-309. PubMed ID: 33155933
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B, Liu Z, Ning H, Zhang K, Pan D, Ding K, Huang W, Kang XL, Wang Y, Chen X.
    Cancer Biomark; 2016 Jul 08; 17(2):223-30. PubMed ID: 27434290
    [Abstract] [Full Text] [Related]

  • 12. A circulating miRNA assay as a first-line test for prostate cancer screening.
    Sharova E, Grassi A, Marcer A, Ruggero K, Pinto F, Bassi P, Zanovello P, Zattoni F, D'Agostino DM, Iafrate M, Ciminale V.
    Br J Cancer; 2016 Jun 14; 114(12):1362-6. PubMed ID: 27228285
    [Abstract] [Full Text] [Related]

  • 13. Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
    Kang HW, Byun YJ, Moon SM, Kim K, Piao XM, Zheng CM, Moon SK, Choi YH, Kim WT, Kim YJ, Lee SC, Yun SJ, Kim WJ.
    Investig Clin Urol; 2022 Mar 14; 63(2):238-244. PubMed ID: 35244999
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE, Aguayo A, Martínez B, Rodríguez F, Marmolejo M, Svyryd Y, Luna L, Muñoz LA, Jiménez MA, Sotomayor M, Vargas V F, Mutchinick OM.
    Clin Genitourin Cancer; 2018 Aug 14; 16(4):e867-e877. PubMed ID: 29571584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
    Ambrozkiewicz F, Karczmarski J, Kulecka M, Paziewska A, Cybulska M, Szymanski M, Dobruch J, Antoniewicz A, Mikula M, Ostrowski J.
    Biomed Res Int; 2020 Aug 14; 2020():9086829. PubMed ID: 32462034
    [Abstract] [Full Text] [Related]

  • 19. Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.
    Byun YJ, Piao XM, Jeong P, Kang HW, Seo SP, Moon SK, Lee JY, Choi YH, Lee HY, Kim WT, Lee SC, Cha EJ, Yun SJ, Kim WJ.
    Investig Clin Urol; 2021 May 14; 62(3):340-348. PubMed ID: 33834642
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic significance of miR-21, miR-141, miR-18a and miR-221 as novel biomarkers in prostate cancer among Egyptian patients.
    Ibrahim NH, Abdellateif MS, Kassem SH, Abd El Salam MA, El Gammal MM.
    Andrologia; 2019 Nov 14; 51(10):e13384. PubMed ID: 31483058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.